MiR‑370 inhibits the oxidative stress and apoptosis of cardiac myocytes induced by hydrogen peroxide by targeting FOXO1
- Authors:
- Published online on: August 16, 2019 https://doi.org/10.3892/etm.2019.7908
- Pages: 3025-3031
-
Copyright: © Qiu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
Cardiovascular disease has the highest rates of morbidity and mortality worldwide (1), as it results in cardiac remodeling which is associated with the potential pathological changes observed in most heart diseases, including heart failure, myocardial infarction (MI), atrial fibrillation, atherosclerosis (AS) and ischemia/reperfusion (IR) (2). MI is one of the main factors that threatens human health and causes cardiac cell death (3). During MI, myocardial cells suffer ischemia and hypoxia for a long period of time, which can lead to irreversible cell death or apoptosis and cardiac dysfunction (4). Reducing apoptosis of myocardial cells can improve cardiac function and cardiac remodeling process after MI (5).
Oxidative stress and apoptosis play a crucial role in the development of cardiovascular diseases (6). The balance between oxidants and antioxidants plays a vital role in maintaining normal biological function. Excessive levels of reactive oxygen species cause serious damage to cardiac myocytes, which can damage the oxidation-antioxidant equilibrium system (7). In addition, further damage can lead to apoptosis (8). Therefore, mitigation of oxidative stress and direct intervention in inhibiting apoptotic pathways can provide potential molecular targets for treatment (9,10).
MicroRNAs (miRs/miRNAs) are a class of non-coding RNA molecules, 18–24 nucleotides long, that are endogenous, conserved and can degrade or inhibit the translation of their target mRNAs, thereby regulating gene expression and playing an important role in a wide range of biological processes (11–13). There is an increasing body of evidence that has indicated the important role of miRNAs in a number of types of cardiac diseases (14–16). Although the functions of miR-370 in different diseases are controversial, miR-370 has always been considered to be a tumor suppressor in a number of types of human cancers. For example, miR-370 was downregulated in endometrioid ovarian cancer by regulating endoglin to suppress cell proliferation and induce cell apoptosis (17). Feng et al (18) illustrated that there was significant downregulation of miR-370 in gastric cancer tissues and cells targeting progestin and AdipoQ receptor family member 4. It has been reported that the expression of miR-370 was decreased in AS models and upregulation of miR-370 could inhibit vascular inflammation and oxidative stress (19). Furthermore, the expression of miR-370 in the myocardium was reported to decrease after MI (20). However, the expression of miR-370 in cardiac myocytes after induction with hydrogen peroxide (H2O2) and the corresponding mechanisms on oxidative stress and apoptosis have not been studied.
H2O2 has been extensively used to induce an apoptotic response in different cell types and the H9C2 cell line is frequently used to study oxidative stress induced cardiomyocyte apoptosis (21). Therefore, the aim of this present study was to investigate the effect of miR-370 on H2O2-induced myocardial damage in H9C2 cells via oxidative stress and apoptosis.
Materials and methods
Cell culture and treatment
The H9C2 cardiomyocytes were purchased from the American Type Culture Collection. Cells were cultivated in 10% fetal bovine serum (FBS; Beyotime Institute of Biotechnology) and 1% penicillin/streptomycin DMEM (Beyotime Institute of Biotechnology) and incubated at 37°C in an atmosphere containing 5% CO2. The cells were subjected to H2O2 (50, 100 and 200 µM; Merck KGaA) solution in DMEM without FBS treatment for 4 h.
Cell transfection
H9C2 cells were seeded into 12-well plates with 1×106 cells/well and cultured in serum-free DMEM at 37°C with 5% CO2 continuously to ensure that cell confluence reached 80% before transfection. According to the manufacturer's protocol, miR-370 mimics (cat. no. miR10000722-1-5), negative control (NC) mimic (cat. no. miR1190315051351), small interfering RNA (siR-/siRNA)-Forkhead box O1 (FOXO1)-1 (5′-GGACAACAACAGTAAATTT-3′), siR-FOXO1-2 (5′-GCACCGACTTTATGAGCAA-3′) and NC siRNA (cat. no. siT0000003-1-5) (Each, 100 nM; all, Guangzhou RiboBio Co., Ltd.) were transfected into H9C2 cells for 48 h using Lipofectamine 2000™ reagent (Invitrogen; Thermo Fisher Scientific, Inc.).
Cell viability assay
Cell Counting Kit-8 (CCK-8; Dojindo Molecular Technologies, Inc.) was used to assess cardiomyocyte viability. After H9C2 cells were treated with H2O2, 10 µl CCK-8 solution was added to each well and the cells were incubated at 37°C for 4 h. Finally, the optical density of each well was measured at a wavelength of 490 nm using a plate reader (Infinite® 200 PRO NanoQuant; Tecan Group, Ltd.).
ELISA
The concentrations of plasma superoxide dismutase (SOD; cat. no. ml077379), malondialdehyde (MDA; cat. no. ml077384) and lactate dehydrogenase (LDH, ml003416) were measured using commercial ELISA kits (Shanghai Enzyme-linked Biotechnology Co., Ltd.) according to the manufacturer's protocols. The experimental groups were as follows: Control group, H9C2 cells untreated with H2O2; H2O2 group, H9C2 cells treated with H2O2; NC mimic +H2O2 group, H9C2 cells treated with NC mimic after H2O2; miR-370 mimic+ H2O2 group, H9C2 cells treated with miR-370 mimic after H2O2; NC siRNA+ H2O2 group, H9C2 cells treated with NC siRNA after H2O2; and siR-FOXO1-1+ H2O2 group, H9C2 cells treated with siR-FOXO1-1 after H2O2.
Flow cytometry assay
Cell apoptosis was evaluated using an Annexin V-FITC Apoptosis Detection kit (BD Biosciences; Becton, Dickson and Company) in accordance with the manufacturer's protocol. The cells were treated as described above. All adhering and floating cells were harvested, washed twice with PBS, transferred into sterile centrifuge tube and then stained successively with propidium iodide (10 µl) and Annexin-V-FITC (10 µl; Nanjing KeyGen Biotech Co., Ltd.) for 15 min at 37°C. A flow cytometer (BD Biosciences; Becton, Dickson and Company) was used to assess apoptotic cells and data were analyzed using CellQuest software (version 3.1, BD Biosciences). Experiments were repeated three times independently.
Reverse transcription-quantitative PCR (RT-qPCR)
Total RNA was extracted from cells using TRIzol reagent (Thermo Fisher Scientific, Inc.). Then, the total RNA was used to synthesize cDNA using a PimeScript RT master mix kit (Takara Biotechnology Co., Ltd.) following the manufacturer's protocol. The RT conditions were as follows: 10 min at 25°C, 30 min at 45°C and 5 min at 95°C. qPCR was performed with the following thermocycling condition: 95°C for an initial 10 min followed by 40 cycles of denaturation for 15 sec at 95°C, annealing at 60°C for 30 sec and extension at 72°C for 30 sec with the SYBR Premix Ex Taq (Applied Biosystems; Thermo Fisher Scientific, Inc.). Fold-changes of miR-370 and mRNA levels were calculated using the 2−ΔΔCq method (22). U6 and GAPDH were used as the endogenous controls. The following primers were used: GAPDH forward, 5′-AGACAGCCGCATCTTCTTGT-3′ and reverse, 5′-TGATGGCAACAATGTCCACT-3′; U6 forward, 5′-CTCGCTTCGGCAGCACA-3′, and reverse, 5′-AACGCTTCACGAATTTGCGT-3′; miR-370 forward, 5′-TACTCAGGATCCTGTGCAAGGCGGGCTACT-3′ and reverse, 5′-TACTCAAAGCTTCCCTCCCTCACCCAAATC-3′; FOXO1 forward, 5′-AGGATCCGATGTCACCATGGCCG-3′ and reverse, 5′-AAAGGATCCACCATGGCCG-3′.
Western blot analysis
The total proteins from cells were isolated using RIPA lysis buffer (Beyotime Institute of Biotechnology) and the concentration of protein was measured with a bicinchoninic acid kit (Beyotime Institute of Biotechnology). Subsequently, an equal quantity of proteins (20 µg) was separated by 10% SDS-PAGE and then transferred onto polyvinylidene fluoride membranes (EMD Millipore). Then the membranes were blocked with 5% non-fat dry milk for 1 h at room temperature. After washing, the membranes were incubated with primary antibodies against FOXO1 (1:1,000; cat. no. 2880) and GAPDH (1:2,000; cat. no. 5174) from Cell Signaling Technology, Inc. at 4°C overnight and washed with 0.1% Tris-Buffered Saline with Tween 20, followed by incubation with horseradish peroxidase conjugated secondary antibodies (1:3,000; cat. no. ab214880; Abcam) for 1 h at room temperature. Blots were developed using an enhanced chemiluminescence film kit (Perkin Elmer, Inc.) and the images were analyzed using ImageJ software (version 1.8.0; National Institutes of Health). All experiments were repeated three times independently.
Dual luciferase reporter assays
The online bioinformatics tool, TargetScan (http://www.targetscan.org/vert_71/), was used to predict the possible binding targets of miR-370 and FOXO1. A fragment of the FOXO1-3′ untranslated region (UTR) containing the miR-370 predicted seed region (wild-type; WT) was amplified from the cDNA of cells and inserted into pGL-3 plasmids (Promega Corporation). The H9C2 cells were co-transfected with the WT 3′UTR of FOXO1 containing the miR-370 binding sites and mutant FOXO1 3′UTR with NC mimics or miR-370 mimics using Lipofectamine 2000™ (Thermo Fisher Scientific, Inc.). Luciferase activity was measured by the Dual Luciferase Reporter Assay system (Promega Corporation), normalizing to Renilla luciferase activity. All experiments were repeated three times independently.
Statistical analysis
All data were presented as the mean ± standard deviation. SPSS v20.0 software (IBM Corp.) was used to analyze the data. Additionally, a Student's t-test was used to determine differences between two groups, while one-way analysis of variance followed by the Dunnett's post hoc test were used for multiple comparisons. P<0.05 was considered to indicate a statistically significant difference.
Results
Cell viability and the expression of miR-370 are inhibited by H2O2 in cardiomyocytes
The H9C2 cells were treated with H2O2 at different concentrations (0, 50, 100 and 200 µmol/l) for 4 h. Then, the cell viability was detected using a CCK-8 assay. As shown in Fig. 1, when compared with the control (0 µmol/l H2O2) group, the activity of H9C2 cells treated with oxidative stress was concentration dependent and cell viability significantly decreased with the increasing concentration (P<0.01). A dose of 100 µmol/l (cell viability, 50%) was selected for subsequent experiments.
miR-370 overexpression attenuates H2O2-induced oxidative stress and apoptosis in H9C2 cells
The H2O2-induced H9C2 cells were transfected with the miR-370 mimic or NC mimic vectors. Subsequently, RT-qPCR was performed to detect the expression levels of miR-370. As shown in Fig. 2A, the expression of miR-370 was significantly decreased in the H2O2-induced H9C2 cells when compared with the normal H9C2 cells (P<0.001); however, the expression of miR-370 was significantly increased in H9C2 cells transfected with miR-370 mimic when compared with the NC mimic group (P<0.001; Fig. 2A). The results indicated that miR-370 expression could be inhibited by H2O2 in H9C2 cells, which in turn suggested that miR-370 may be downregulated in myocardial cells with ischemia and hypoxia.
To verify miR-370 function in oxidative stress and apoptosis, an ELISA was used to detect SOD, MDA and LDH levels in the supernatant, and a flow cytometry assay was used to detect apoptosis. As exhibited in Fig. 2B, when compared with the control group, SOD expression significantly decreased (P<0.001) and MDA and LDH expression significantly increased in the H2O2 and NC mimic groups (P<0.01). Compared with the H2O2 and NC mimic groups, SOD expression increased, and MDA and LDH expression reduced in the miR-370 mimics group. Furthermore, the results of flow cytometry revealed that the rate of apoptosis was significantly increased in the H2O2 and NC mimic groups when compared with the control group (P<0.001; Fig. 2C and D). Compared with the H2O2 and NC mimic groups, the rate of apoptosis was decreased in the miR-370 mimics group. These findings suggested that the overexpression of miR-370 could markedly suppress the oxidative stress and apoptosis induced by H2O2.
Luciferase reporter assay for target verification
The results of the online bioinformatics tool TargetScan suggested that FOXO1 was predicted to be a possible target gene of miR-370. A luciferase reporter assay was conducted to verify this prediction. As shown in Fig. 3, the 3′-UTR of the gene FOXO1 was shown to contain the binding sequences for miR-370, suggesting that FOXO1 may be a downstream target gene of miR-370. Luciferase activity was significantly reduced in the FOXO1 3′UTR WT group transfected with miR-370-3p mimics (P<0.001), whereas there was no variation in the mutant-type FOXO1 3′UTR, therefore also suggesting that FOXO1 may be a direct target gene of miR-370.
FOXO1 expression is increased in H2O2-induced H9C2 cells
The mRNA and protein levels of FOXO1 were measured by RT-qPCR and western blotting assay. As shown in Fig. 4A and B, the expression of FOXO1 was markedly increased in the H2O2 and NC mimic groups when compared with the control group. Compared with the H2O2 and NC mimic groups, FOXO1 expression was decreased in the miR-370 mimic group. Then, the interference efficiency of FOXO1 siRNA plasmids was detected using RT-qPCR and western blot assays. As shown in Fig. 4C and D, the expression of FOXO1 was significantly reduced in the siR-FOXO-1 and siR-FOXO1-2 groups when compared with the NC siRNA group (P<0.001). The siR-FOXO1-1 plasmid with the best interference effects was selected for subsequent experiments.
FOXO1 silencing inhibits oxidative stress and apoptosis in H2O2-induced H9C2 cells
ELISA was used to detect the levels of SOD, MDA and LDH in the supernatant, and a flow cytometry assay was used to detect apoptosis in H2O2-induced H9C2 cells. As shown in Fig. 5A, compared with the control group, the level of SOD significantly decreased (P<0.001) and the levels of MDA and LDH were significantly increased in the H2O2 and NC siRNA groups (P<0.001). However, compared with the H2O2 and NC siRNA groups, SOD expression significantly increased (P<0.01), and MDA and LDH expression significantly decreased in the siR-FOXO1-1 group (P<0.01). The results of flow cytometry revealed that the rate of apoptosis was significantly increased in the H2O2 and NC siRNA groups when compared with the control group (P<0.001; Fig. 5B and C). In addition, compared with the H2O2 and NC siRNA groups, the rate of apoptosis was significantly decreased in the siR-FOXO1-1 group (P<0.01). These results suggested that knockdown of FOXO1 could markedly suppress the oxidative stress and apoptosis of H9C2 cells induced by H2O2.
Discussion
The results of the present study revealed that the expression of miR-370 was decreased in H2O2-induced H9C2 cells. In addition, miR-370 overexpression attenuated H2O2-induced oxidative stress and apoptosis in H9C2 cells. Nevertheless, the underlying mechanism of miR-370 in ischemic heart disease remains largely unknown. In vitro experiments are required to further explore the effect of miR-370, in order to provide the theoretical basis for the research.
After maturation, miRNA can regulate gene expression via complementation with target mRNA and regulating cell differentiation proliferation, metabolism, and apoptosis (23–26). It has been indicated that miR-370 is involved in various types of heart diseases (27,28). A number of studies have published their results on miR-370 in cardiovascular diseases; however, the results are controversial. A previous study reported that miR-370 was significantly higher in patients with coronary artery disease (29). Additionally, miR-370 was reported to be upregulated in peripheral blood mononuclear cells of coronary AS patients (30). By contrast, miR-370 has also been found to have a positive effect in different diseases. Consistent with a previous study, the expression level of miR-370 markedly decreased in AS mouse models and oxidized low-density lipoprotein incubated THP-1 cells, and miR-370 overexpression inhibited vascular inflammation and oxidative stress (19). In myocardial remodeling, the expression of miR-370 in the infarct border area was decreased after MI, but myocardial fibrosis was suppressed through the intervention of miR-370 (20). The positive role of miR-360 is consistent with the results of the present study, the expression of miR-370 was markedly decreased in H9C2 cells induced by H2O2.
In the present study, H2O2 had proapoptotic effects on H9C2 cells. Hypoxia is the main cause of ischemic heart disease which leads to autophagy and apoptosis through the activation of a caspase cascade via the release of cytochrome c from the mitochondria to the cytoplasm (31). H2O2 activated oxidative stress through the downregulation of SOD levels and upregulation of MDA and LDH levels in the present study. In addition, H2O2 induced apoptosis by downregulating Bcl-2 and upregulating the expression of proapoptotic proteins, such as Bax, caspase-8, and cleaved-caspase-3 (32). Oxidative stress and apoptosis are involved in cardiovascular diseases. For example, the overexpression of miRNA-132 increased the anti-oxidative stress and anti-apoptotic abilities of H9C2 cells in heart failure (33). The present study demonstrated that overexpression of miR-370 suppressed the oxidative stress and apoptosis induced by H2O2.
FOXO1 is an essential regulator of endothelial cell proliferation and can be modulated by a number of signaling pathways (34). In osteoblasts, FOXO1 expression was increased when induced by H2O2 (35). Therefore, the present study speculated that FOXO1 may also be involved in the apoptosis of cardiac myocytes induced by oxidative stress. TargetScan analysis suggested that transcription factor FOXO1 was a possible target gene of miR-370. As the results demonstrated, FOXO1 expression was increased in H9C2 cells induced by H2O2. Furthermore, FOXO1 silencing suppressed H2O2-induced oxidative stress and apoptosis in H9C2 cells. These results indicated that FOXO1 was involved in H2O2-induced oxidative stress and apoptosis, which was consistent with the hypothesis of the present study.
However, some limitations should be considered in the present study, the H9C2 cells are not mature cardiomyocytes and only an in vitro model, which does not entirely explain the results in physiological and pathological processes. Therefore, future studies will be needed to confirm the present results in IR with in vivo models.
In conclusion, the results of the present study indicate that FOXO1 was a target gene of miR-370, and miR-370 reduced H2O2-induced oxidative stress and apoptosis in H9C2 cells by targeting FOXO1, which provides a theoretical basis for the treatment of ischemic heart disease.
Acknowledgements
Not applicable.
Funding
The present study was supported by the Shandong Medical and Health Science and Technology Development Plan Project (grant no. 2018WS193), Science and the Technology Development Plan Project of Jinan (grant no. 201602184), and the Shandong Province TCM Science and Technology Development Plan (grant no. 2015-091).
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding authors on reasonable request.
Authors' contributions
ZJQ, LW, LNW and YGC designed the research. ZJQ, LW, HYM, FX and BS performed the experiments. ZJQ, LW, XBL, JLW and FK analyzed the data. ZJQ, LW, HYM and FX drafted the manuscript and analyzed data. LNW and YGC interpreted data and revised the final manuscript. ZJQ and LW wrote the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Not applicable.
Patient consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
References
Poole-Wilson P: The prevention of cardiovascular disease worldwide: Whose task and WHO's task? Clini Med (Lond). 5:379–384. 2005. View Article : Google Scholar | |
Porter KE and Turner NA: Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther. 123:255–278. 2009. View Article : Google Scholar : PubMed/NCBI | |
Qiu H, Liu JY, Wei D, Li N, Yamoah EN, Hammock BD and Chiamvimonvat N: Cardiac-generated prostanoids mediate cardiac myocyte apoptosis after myocardial ischaemia. Cardiovasc Res. 95:336–345. 2012. View Article : Google Scholar : PubMed/NCBI | |
Katz AM and Messineo FC: Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res. 48:1–16. 1981. View Article : Google Scholar : PubMed/NCBI | |
Abbate A and Narula J: Role of apoptosis in adverse ventricular remodeling. Heart Fail Clin. 8:79–86. 2012. View Article : Google Scholar : PubMed/NCBI | |
Navarro-Yepes J, Burns M, Anandhan A, Khalimonchuk O, del Razo LM, Quintanilla-Vega B, Pappa A, Panayiotidis MI and Franco R: Oxidative stress, redox signaling, and autophagy: Cell death versus survival. Antioxid Redox Signal. 21:66–85. 2014. View Article : Google Scholar : PubMed/NCBI | |
Morales CR, Pedrozo Z, Lavandero S and Hill JA: Oxidative stress and autophagy in cardiovascular homeostasis. Antioxid Redox Signal. 20:507–518. 2014. View Article : Google Scholar : PubMed/NCBI | |
Ogura S and Shimosawa T: Oxidative stress and organ damages. Curr Hypertens Rep. 16:4522014. View Article : Google Scholar : PubMed/NCBI | |
Farias JG, Molina VM, Carrasco RA, Zepeda AB, Figueroa E, Letelier P and Castillo RL: Antioxidant therapeutic strategies for cardiovascular conditions associated with oxidative stress. Nutrients. 9(pii): E9662017. View Article : Google Scholar : PubMed/NCBI | |
Brown DI and Griendling KK: Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res. 116:531–549. 2015. View Article : Google Scholar : PubMed/NCBI | |
Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI | |
Guo H, Ingolia NT, Weissman JS and Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI | |
Baek D, Villen J, Shin C, Camargo FD, Gygi SP and Bartel DP: The impact of microRNAs on protein output. Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI | |
Orenes-Pinero E, Montoro-Garcia S, Patel JV, Valdes M, Marin F and Lip GY: Role of microRNAs in cardiac remodelling: New insights and future perspectives. Int J Cardiol. 167:1651–1659. 2013. View Article : Google Scholar : PubMed/NCBI | |
Joladarashi D, Thandavarayan RA, Babu SS and Krishnamurthy P: Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration. Int J Mol Sci. 15:15891–8911. 2014. View Article : Google Scholar : PubMed/NCBI | |
Chen C, Ponnusamy M, Liu C, Gao J, Wang K and Li P: MicroRNA as a therapeutic target in cardiac remodeling. Biomed Res Int. 2017:12784362017. View Article : Google Scholar : PubMed/NCBI | |
Chen XP, Chen YG, Lan JY and Shen ZJ: MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG. Cancer Lett. 353:201–210. 2014. View Article : Google Scholar : PubMed/NCBI | |
Feng Y, Sun T, Yu Y, Gao Y, Wang X and Chen Z: MicroRNA-370 inhibits the proliferation, invasion and EMT of gastric cancer cells by directly targeting PAQR4. J Pharmacol Sci. 138:96–106. 2018. View Article : Google Scholar : PubMed/NCBI | |
Tian D, Sha Y, Lu JM and Du XJ: MiR-370 inhibits vascular inflammation and oxidative stress triggered by oxidized low-density lipoprotein through targeting TLR4. J Cell Biochem. 119:6231–6237. 2018. View Article : Google Scholar : PubMed/NCBI | |
Yuan H and Gao J: The role of miR370 in fibrosis after myocardial infarction. Mol Med Rep. 15:3041–3027. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wu H, Gao H, Gao S, Lei Z, Dai L, Wang X, Han Y, Wang Z and Han L: A Chinese 4-herb formula, Yiqi-Huoxue granule, alleviates H2O2-induced apoptosis by upregulating uncoupling protein 2 in H9c2 cells. Phytomedicine. 53:171–181. 2019. View Article : Google Scholar : PubMed/NCBI | |
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI | |
Xu G, Zhu H, Zhang M and Xu J: Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5. Int J Mol Med. 41:155–163. 2018.PubMed/NCBI | |
Qi R, Huang J, Wang Q, Liu H, Wang R, Wang J and Yang F: MicroRNA-224-5p regulates adipocyte apoptosis induced by TNFα via controlling NF-κB activation. J Cell Physiol. 233:1236–1246. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wu J, He D, Yue B, Zhang C, Fang X and Chen H: miR-101-1 expression pattern in Qinchuan cattle and its role in the regulation of cell differentiation. Gene. 636:64–69. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zhang K and Guo L: MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression. Gene. 641:272–278. 2018. View Article : Google Scholar : PubMed/NCBI | |
Tian D, Sha Y, Lu JM and Du XJ: MiR-370 inhibits vascular inflammation and oxidative stress triggered by oxidized low-density lipoprotein through targeting TLR4. J Cell Biochem. 119:6231–6237. 2018. View Article : Google Scholar : PubMed/NCBI | |
Yuan H and Gao J: The role of miR-370 in fibrosis after myocardial infarction. Mol Med Rep. 15:3041–3047. 2017. View Article : Google Scholar : PubMed/NCBI | |
Liu H, Yang N, Fei Z, Qiu J, Ma D, Liu X, Cai G and Li S: Analysis of plasma miR-208a and miR-370 expression levels for early diagnosis of coronary artery disease. Biomed Rep. 5:332–336. 2016. View Article : Google Scholar : PubMed/NCBI | |
Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel TJ and Biessen EA: The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun. 394:792–797. 2010. View Article : Google Scholar : PubMed/NCBI | |
Hu J, Chu Z, Han J, Zhang Q, Zhang D, Dang Y, Ren J, Chan HC, Zhang J and Huang Y: Phosphorylation-dependent mitochondrial translocation of MAP4 is an early step in hypoxia-induced apoptosis in cardiomyocytes. Cell Death Dis. 5:e14242014. View Article : Google Scholar : PubMed/NCBI | |
Chang H, Li C, Huo K, Wang Q, Lu L, Zhang Q, Wang Y and Wang W: Luteolin prevents H2O2-induced apoptosis in H9C2 cells through modulating Akt-P53/Mdm2 signaling pathway. Biomed Res Int. 2016:51258362016. View Article : Google Scholar : PubMed/NCBI | |
Liu X, Tong Z, Chen K, Hu X, Jin H and Hou M: The role of miRNA-132 against apoptosis and oxidative stress in heart failure. Biomed Res Int. 2018:34527482018.PubMed/NCBI | |
Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich MF, Lim R, Zimmermann B, Aspalter IM, Franco CA, Boettger T, et al: FOXO1 couples metabolic activity and growth state in the vascular endothelium. Nature. 529:216–220. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wang Z, Ji G, Wu Q, Feng S, Zhao Y, Cao Z and Tao C: Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting FOXO1. Life Sci. 210:263–270. 2018. View Article : Google Scholar : PubMed/NCBI |